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Abstract 
Peri-implantitis or Periimplantitis is characterized as an inflammatory reaction that affects the hard and soft tissue, 
which results in loss of supporting bone and pocket formation surrounding the functioning osseointegrated implant. 
This review aimed to evaluate the effectiveness of surgical and non-surgical treatment of peri-implantitis. The data 
sources used was PubMed. Searches of this database were restricted to English language publications from January 
2010 to June 2015. All Randomized Controlled Trials describing the treatments of peri-implantitis of human studies 
with a follow up of at least 6 months were included. Eligibility and quality were assessed and two reviewers extracted 
the data. Data extraction comprised of type, intensity provider, and location of the intervention. A total of 20 publica-
tions were included (10 involving surgical and 10 involving non-surgical mechanical procedure). The non-surgical 
approach involves the mechanical surface debridement using carbon or titanium currettes, laser light, and antibiotics 
whereas, surgical approach involves implantoplasty, elevation of mucoperiosteal flap and removal of peri-inflamma-
tory granulation tissue followed by surface decontamination and bone grafting. This study reveals that non-surgical 
therapy tends to remove only the local irritant from the peri-implantitis surface with or without some additional 
adjunctive therapies agents or device. Hence, non-surgical therapy is not helpful in osseous defect. Surgical therapy in 
combination with osseous resective or regenerative approach removes the residual sub-gingival deposits additionally 
reducing the peri-implantitis pocket. Although there is no specific recommendation for the treatment of peri-implan-
titis, surgical therapy in combination with osseous resective or regenerative approach showed the positive outcome.
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Background
Implant based dental rehabilitation technique has come 
to offer steadfast result hence it has become a cardinal 
entrenched therapy in order to restore missing natural 
teeth in regular clinical practice. van Velzen et al. (2014) 
has reported 91.6  % of success rate for dental implant 
and shows 7  % of peri-implantitis after 10  years follow 
up. Dental implant has majority of success rate in long 
term however failure does occur. Peri-implant disease 
which is commenced by bacteria have two subtypes (1) 
Peri-implant mucositis and (2) Peri-implantitis. Peri-
implant mucositis is the reversible inflammatory process 
of the soft tissue surrounding the peri-implant, which is 
followed by reddening, swelling and bleeding on probing 
(Mombelli et al. 2012).
Peri-implantitis or Periimplantitis is characterized 
as an inflammatory reaction that affects the hard and 
soft tissue, which results in loss of supporting bone and 
pocket formation surrounding the functioning osseoin-
tegrated implant (McCrea 2014). Peri-implantitis has 
been put under three categories depending on the pocket 
depth and bone loss (Table 1) (Froum and Rosen 2012).
Implant failure could be due to imbalanced occlusal 
force, smoking habit, poor bone quality, implant 
thread design, improper surgical placement, surgi-
cal trauma, incorrect prosthetic design, poor oral 
hygiene, bacterial infection, diabetes, the particles 
released from implant, etc. Bacterial infection is con-
sidered as the most important factor for implant fail-
ure. Microbiota associated with peri-implantitis are 
Prevotella intermedia, Porphyromonas gingivalis, 
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Aggregatibacter actinomycetemcomitans, Bacterioides 
forsythus, Treponema denticola, Prevotella nigrescens, 
Peptostreptococcus micros, Fusobacterium nucleatum, 
etc. (Ata-Ali et al. 2011).
Peri-implantitis is latent in early stage and usually diag-
nosed during routine dental check up. Hence early diag-
nosis of peri-implantitis is very important to terminate the 
further progression of the diseases and for establishment 
of good osseointegration. Various treatment modalities 
have been put forward for the treatment of peri-implan-
titis, which are summarized in two treatment methods, 
namely resective and regenerative therapies. Resective 
implant treatment attempts to eliminate the etiologic fac-
tors and maintain optimal peri-implant conditions, mainly 
by cleaning the surfaces of the implants; whereas regen-
erative periodontal therapy (using bone grafts, membranes 
and growth factors) aims to regenerate a new attachment 
apparatus and reconstruct the periodontal unit to previ-
ously existing normal physiologic limits (Kim et al. 2011; 
Smeets et al. 2014). An optimal objective of peri-implan-
titis management should be the eradication of the dis-
eases (no bleeding on probing, no further bone loss) and 
formulation of hard and soft peri-implant tissue. This 
review aims to evaluate the ideal surgical treatment of 
peri-implantitis in humans in a broader way than previous 
studies.
The aim of the present study is to assess the effective-
ness of treatment of peri-implantitis.
Review
Rationale and focused question
To our knowledge from indexed literature, there is no 
absolute explanation regarding the effectiveness of surgi-
cal and non-surgical management of peri-implantitis.
The addressed focused question is: “What is the recom-
mended treatment for management of peri-implantitis?”
Search methods to identify relevant studies (Table 2)
An electronic search of database PubMed was conducted. 
Searches were limited to studies involving humans, in Eng-
lish language and published from January 2010 to June 
2015. A random combination of following terms was used 
for the search: “peri implantitis treatment”, “bone graft-
ing peri implantitis”, “therapy peri implantitis”, “dental 
implant inflammation”, and “dental implant bone Loss”. All 
retrieved articles were reviewed to identify additional rel-
evant RCTs. The titles and abstracts of potential references 
were manually examined to exclude irrelevant publications, 
and two reviewers for additional pertinent studies reviewed 
all of the remaining literatures on the topic of interests 
independently.
Table 1 Classification of  peri-implantitis (Froum and 
Rosen 2012)
a Noted one two or more aspects of the implants
b Measured on radiographs from time of definitive prosthesis loading to current 
radiograph. If not available, the earliest available radiograph following loading 
should be used
Early PD ≥4 mm (bleeding and/or suppuration on probing)a
Bone loss <25 % of the implant lengthb
Moderate PD ≥6 mm (bleeding and/or suppuration on probing)a
Bone loss <25–50 % of the implant lengthb
Severe PD ≥8 mm (bleeding and/or suppuration on probing)a
Bone loss >50 % of the implant lengthb
Table 2 Systematic search strategy
Focus question What is the recommended treatment for management of peri-implantitis?
Search strategy
Population Patients diagnosed with peri-implantitis
Intervention or Exposure Treatment
Comparison Non-surgical treatment with surgical treatment
Outcome Resolution of disease: implant survival and absence of PD ≥4 mm with suppuration/BoP and no further bone loss





Inclusion criteria Include patients with at least one dental osseointegrated implant affected by peri-implantitis
Describe a clinical intervention aiming at the treatment of the condition
Describe a pathological condition of peri-implantitis with bone loss
Experimental human studies
Full-text articles (Randomized and Controlled Clinical Trials)
Follow up of at least 6 months
Exclusion criteria No access to an English version of title and abstract
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Eligibility criteria
The following eligibility criteria were imposed: (1) 
Original articles; (2) Experimental human studies; (3) 
Reference list of pertinent original and review stud-
ies; (4) Intervention: Effectiveness of peri-implantitis 
after surgical and non-surgical treatment; (5) Articles 
published only in English-language; and (6) Full-text 
articles (Randomized and Controlled Clinical Trials). 
Letters to the editor, historic reviews, abstract with 
no full text articles and unpublished articles were 
excluded.
Data extraction and quality assessment
All datas from the eligible studies were extracted by two 
independent reviewers with a predefined table (Table 3). 
Data tables were designed to extract all relevant data 
from texts, tables and figures, including author, year, 
implant number, treatment method, duration of follow 
up and the outcomes.
Study selection
At each stage of the study screening, two reviewers inde-
pendently reviewed the studies and made selections for 
inclusion (Fig.  1). All selected studies were screened by 
title and abstract, and the full texts of the relevant papers 
were then reviewed.
Statistical analysis
A meta-analysis of trial data was not possible due to het-
erogeneity in trial design and outcomes reported. Data 
related to trial quality was therefore subject to narrative 
synthesis. Trial quality was assessed using the Critical 
Appraisal Skills Programme and PRISMA-2009 Checklist.
Risk of bias included in studies
There could be potential language bias in this system-




Using the search strategy above, 2253 articles were 
retrieved. After reviewing title and abstracts, 2230 
of those articles were excluded and 23 studies were 
included because the focus of this review is rand-
omized controlled trials on therapy of peri-implantitis 
(Fig. 1). Among 23 studies, we excluded 2 because these 
2 studies did not meet the criteria to diagnose peri-
implantitis and another 1 study which failed to meet 
the criteria of at least 6  month follow up. In total, 20 
articles were included in this review. The pattern of the 




Bio-film and bacteria on the surface of implant plays 
an important role in the appearance of peri-implantitis 
(Canullo et al. 2015). The management of peri-implantitis 
is focused on infection and bacterial controls. The treat-
ments proposed for peri-implant disease are based on 
the evidence gained from the treatment of periodonti-
tis. Both surgical and non-surgical techniques have been 
developed for the treatment of peri-implantitis.
Non‑surgical techniques
The treatment of peri-implantitis in the case of incipient 
bone loss involves the elimination of local irritants with 
or without surface decontamination, systemic antibiotics, 
some additional adjunctive therapies agents or devices 
(Machtei 2014).
In the articles included in our review (Table  3), a total 
of 730 patients were treated with a follow up period of 
6 months to 4 years with a pocket depth of >4 mm, radio-
logical confirmed bone loss of ≥1.5 mm, exposed implant 
thread, absence of mobility and the presence of bacteria.
The studies compared ultrasound and carbon fiber 
curettes; curettage with or without antibiotics; conven-
tional scaling and the Er:YAG laser.
Mechanical treatments Karring et  al. (2005) com-
pared the treatment results obtained with the Vector® 
ultrasound system and with carbon fiber curettes. After 
6  months of follow-up, no significant differences were 
found between the two techniques, and neither proved 
sufficient to treat peri-implantitis. Same results were 
obtained by Persson et al. (2010) with titanium curettes 
and with ultrasonic device. After 6  month of follow up, 
no differences were found to reduce microbiota neither 
proved sufficient to treat peri-implantitis.
The study conducted by Sham et  al. (2011) compared 
mechanical debridement using carbon curettes and antisep-
tic therapy (MDA) with amino acid glycine powder (AAD). 
After 6  months of follow up treatment both study group 
resulted in limited clinical attachment level and the bleeding 
was reduced in AAD group as compared to MDA group.
 Schwarz et al. (2006b), Renvert et al. (2011) and Pers-
son et  al. (2011) compared the Er:YAG laser with air 
abrasive device. The author recorded limited improve-
ment in clinical parameters in both the group but the 
bacterial count was not reduced after 6 month of follow 
up.
Mechanical treatments associated to  antibiotics The 
two studies of Renvert et  al. (2006, 2008) published in 
the year 2006 and 2008 evaluated the treatment in 32 
patients, comparing local minocycline microspheres 
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and chlorhexidine gel debridement. After 1 year of treat-
ment both study group showed improvement in plaque 
index, pocket depth and bleeding without improvement 
in terms of microbiota. In relation to bacterial load, there 
were no differences in the change in bacterial composi-
tion in the two groups after treatment and further studies 
were needed to establish how often such treatment must 
be repeated. Similarly Schar et  al. (2013) examined the 
benefit of photodynamic therapy (PDT) over minocycline 
microspheres. In both group significant reductions in 
mucosal inflammation was observed up to 6 month.
The studies published by Hallstrom et al. (2012) in 2012 
had used systemic antibiotic azithromycin for 4  days. 
After 6 months of follow up, there was improvement only 
in oral hygiene but this study could not provide evidence.
Machtei et  al. (2012) evaluated and compared the 
matrix chips (MatrixC) with that of chlorhexidine chips 
(PerioC) in 60 patients with probing depth 6–10  mm 
and bone loss >2 mm. The results yields after 6 month of 
repeated treatment shows probing depth reduction was 
greater in the PerioC (2.19 ±  0.24  mm) compared with 
MatrixC (1.59 ± 0.23 mm). Half in both groups reduced 
bleeding on probing. Clinical attachment level gains for 
both groups were significant. However, to fully appreciate 
mechanism of this treatment, a further study is needed.
Surgical techniques
Surgical treatment of peri-implantitis lesions may be 
performed in cases with considerable pocket formation 
(larger than 5  mm) and bone loss. Surgical techniques 
can be divided into resective and regenerative surgery. 
These techniques is used depending upon the type of 
bony defects whereas Schwarz et al. (2014) have demon-
strated that combined surgical procedure is effective in 
controlling advanced peri-implantitis lesion.
Aghazadeh et  al. (2012) concluded that resective sur-
gical procedures coupled with bovine derived xenograft 
and placement of collagen membrane have more radio-
graphic evidence of bony defect filled as compared to 
autogenous bone graft.





2230 publications excluded due to 
inappropriate study design & 10 
publications excluded depending on 
title/abstract
Full-text articles assessed for 
eligibility
(n =23)
Full-text articles excluded, 
(n = 3)
-Inappropriate population (2)
-Inappropriate study design (1)
























Fig. 1 PRISMA flow chart
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The 2-years result by Schwarz et  al. (2008) demon-
strated that both nanocrystalline hydroxyapatite and 
application of the combination of natural bone min-
eral and collagen membrane were efficacious in provid-
ing clinical significant reduction of the pocket probing 
depth and gain in clinical attachment level but in the 
4  year study of Schwarz et  al. (2009) application of the 
combination of natural bone mineral and collagen mem-
brane were more efficacious in clinical improvement as 
compared to nanocrystalline hydroxyapatite. But the 
6 months of Schwarz et al. (2006a) study concluded the 
application of nanocrystalline hydroxyapatite and guided 
tissue regeneration showed significant improvement in 
clinical parameters.
Wohlfahrt et  al. (2012) evaluated the 12  months out-
come by adding porous titanium granules (PTG) together 
with an open flap procedure and in conjunction with 
mechanical debridement of the implant surface for 
decontamination with 24  % ethylenediaminetetracetic 
acid gel followed by antibiotics (amoxicillin and met-
ronidazole) 3  days prior to surgery and for 7  days after 
surgery. Both the treatment demonstrated significant 
improvements in probing pocket depth but the recon-
struction with PTG resulted in better radiographic peri-
implant defect fill.
Romeo et  al. (2007) have compared the efficacy of 
resective surgery with that of implantoplasty. The 
results obtained after 3  years of therapy demonstrated 
that the marginal bone loss was significantly lower after 
implantoplasty.
Schwarz et  al. (2011, 2012) in two studies (2011 
and 2012) of advanced peri-implantitis evaluated and 
compared the efficacy of Er:YAG laser (ERL) surface 
debridement/decontamination (DD) with that of plas-
tic curettes and cotton pellets (CPS) soaked in sterile 
saline and both procedure were followed by an implan-
toplasty at the exposed implant surface and were aug-
mented with a natural bone mineral and covered with 
a collagen membrane. After 24  months of treatment, 
CPS group yield significant reduction in bleeding on 
probing and the radiographic bone fill at the intra-
bony defect were same in both groups but the clinical 
attachment values were not significantly different in 
both groups.
The study by de Waal et  al. (2013) demonstrated that 
the adjunctive benefits derived from the addition of 
resective surgical treatment consisting of apically re-posi-
tioned flap, bone re-contouring and surface debridement 
and with 0.12 % CHX + 0.05 % CPC to a placebo-solu-
tion (without CHX/CPC) tend to be greater immediate 
suppression of anaerobic bacteria on the implant surface 
than a placebo-solution, but does not lead to superior 
clinical results.
Discussion
The treatment protocol differs depending upon whether 
it is peri-implant mucositis or peri-implantitis. Until 
now, no particular treatment protocol has been shown 
effective. There are number of treatment protocol for 
the resolution of diseases. But this study highlighted that 
diseases resolution is satisfactory by surgical treatment. 
Peri-implant mucositis can be treated by non-surgical 
treatment (Schar et  al. 2013). If the peri-implantitis is 
diagnosed then the treatment protocol depends on the 
intraosseous defect. If the bony defect is minimum then 
implantoplasty can improve the bony defect (Romeo 
et al. 2007).
Non-surgical treatment could improve significant clini-
cal parameters but bacterial pathogens are not reduced. 
Treatment standard of peri-implantits can be improved 
by decreasing the bacterial pathogen hence it is effective 
if resective surgery is followed in the incipient case of 
peri-implantitis as well.
In the advanced peri-implantitis combined treatment 
of resective and regenerative surgical procedure fol-
lowed by surface decontamination yields good osseo-
integration (Schwarz et  al. 2012). de Waal et  al. (2013) 
study concluded that surface decontamination/debride-
ment reduce bacterial count but there was no superior 
improvement in clinical parameters hence guided bone 
regeneration (Aghazadeh et  al. 2012) or the application 
of bone substitute (Schwarz et  al. 2009) (nanocrystal-
line hydroxyapetite) can be efficacious for the treatment 
of peri-implantitis. The majority of surgical protocols 
include pre-operative or post-operative systemic anti-
biotics followed by post-operative chlorhexidine rinse. 
Maintenance phase after surgery is also important which 
include oral hygiene instructions and surface biofilm 
removal.
Although we performed a comprehensive analysis of 
the effects of surgical and non-surgical treatment, there 
were some limitations to this systematic review. First, our 
systematic review could not provide the implant survival 
rate because of insufficient eligible information. Second, 
high quality study with survival rate was not there which 
may compromise our conclusion. There could be poten-
tial language bias in this systematic review as we only 
considered literature written in English.
Conclusions
Complete osseointegration is difficult to achieve. Even 
though the different treatment modalities cannot be 
comparable, however the outcome of surgical treatment 
of peri-implantitis is good. Surgical procedures for peri-
implantitis in human have shown positive results but 
long-term study is needed to achieve the reliability of the 
treatment.
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